Cook Anne Marie
Insider CIK 1320559 · AEGR SVP, General Counsel · SAGE Senior VP, General Counsel · PHAT Chief Legal Off. & Corp. Sec.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals, I | F Tax w/h | 2026-02-10 | 2026-02-12 | 1,535 | $12.82 | $19.7K | 88,660 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2026-02-10 | 2026-02-12 | 3,461 | — | $0 | 90,195 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2026-01-02 | 2026-01-02 | 67,878 | — | $0 | 67,878 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2026-01-02 | 2026-01-02 | 75,345 | — | $0 | 85,012 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2025-12-17 | 2025-12-19 | 17,370 | — | $0 | 17,370 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | F Tax w/h | 2025-12-17 | 2025-12-19 | 7,703 | $15.36 | $118.3K | 9,667 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2025-06-23 | 2025-06-24 | 210,000 | — | $0 | 210,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2024-08-05 | 2024-08-07 | 13,500 | — | $0 | 28,543 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2024-08-05 | 2024-08-07 | 4,503 | $8.96 | $40.3K | 24,040 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 22,500 | — | $0 | 22,500 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2024-02-13 | 2024-02-15 | 11,250 | — | $0 | 25,181 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2023-11-28 | 2023-11-30 | 4,000 | — | $0 | 14,890 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2023-11-28 | 2023-11-30 | 1,174 | $19.27 | $22.6K | 13,716 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2023-02-13 | 2023-02-15 | 19,000 | — | $0 | 19,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2023-02-03 | 2023-02-07 | 2,850 | — | $0 | 11,478 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2023-02-03 | 2023-02-07 | 980 | $44.16 | $43.3K | 10,498 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 15,200 | — | $0 | 15,200 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2021-10-19 | 2021-10-21 | 1,116 | $40.29 | $45.0K | 7,894 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2021-10-19 | 2021-10-21 | 3,800 | — | $0 | 9,010 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2021-06-15 | 2021-06-17 | 4,000 | — | $0 | 6,117 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2021-06-15 | 2021-06-17 | 1,144 | $58.80 | $67.3K | 4,973 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 19,000 | — | $0 | 19,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2020-04-28 | 2020-04-30 | 9,450 | — | $0 | 9,450 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2020-02-12 | 2020-02-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2019-07-25 | 2019-07-29 | 844 | $161.38 | $136.2K | 1,756 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2019-07-25 | 2019-07-29 | 1,900 | — | $0 | 2,600 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2019-06-21 | 2019-06-25 | 9,240 | — | $0 | 18,480 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise deriv | 2019-05-10 | 2019-05-10 | 700 | — | $0 | 109,300 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise deriv | 2019-05-10 | 2019-05-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise | 2019-05-10 | 2019-05-10 | 15,000 | $28.63 | $429.4K | 15,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | S Sale | 2019-05-10 | 2019-05-10 | 15,000 | $166.14 | $2.49M | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | M Exercise | 2019-05-10 | 2019-05-10 | 700 | $56.27 | $39.4K | 700 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2019-02-13 | 2019-02-15 | 19,000 | — | $0 | 19,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2018-12-07 | 2018-12-11 | 9,240 | — | $0 | 9,240 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2018-04-02 | 2018-04-04 | 31,500 | — | $0 | 31,500 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2017-02-06 | 2017-02-08 | 56,000 | — | $0 | 56,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2016-12-08 | 2016-12-16 | 10,000 | — | $0 | 40,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2016-02-08 | 2016-02-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2015-09-16 | 2015-09-18 | 110,000 | — | $0 | 110,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-08-04 | 2015-08-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-12-31 | 2015-01-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-04-01 | 2014-04-21 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2013-04-01 | 2013-04-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2012-01-03 | 2012-01-05 | 115,000 | — | $0 | 115,000 | SEC↗ |